Prathyusha Duraibabu

CIK: 0001779092

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)12 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ORGO

Organogenesis Holdings Inc.

Director

SGMO

SANGAMO THERAPEUTICS, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

ORGO
Organogenesis Holdings Inc.
Feb 18, 2026
Award(A)
Direct
48.8K shares-
SGMO
SANGAMO THERAPEUTICS, INC
Jan 22, 2026
Tax Payment(F)
Direct
36.7K shares at avg. $0.40$15K
SGMO
SANGAMO THERAPEUTICS, INC
Nov 24, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $0.42$1K
SGMO
SANGAMO THERAPEUTICS, INC
Oct 22, 2025
Tax Payment(F)
Direct
45.2K shares at avg. $0.66$30K
SGMO
SANGAMO THERAPEUTICS, INC
Aug 24, 2025
Tax Payment(F)
Direct
1.8K shares at avg. $0.59$1K
SGMO
SANGAMO THERAPEUTICS, INC
Jul 22, 2025
Tax Payment(F)
Direct
31.9K shares at avg. $0.48$15K
SGMO
SANGAMO THERAPEUTICS, INC
May 24, 2025
Tax Payment(F)
Direct
1.8K shares at avg. $0.47$848.154
SGMO
SANGAMO THERAPEUTICS, INC
Apr 22, 2025
Tax Payment(F)
Direct
31.9K shares at avg. $0.78$25K
SGMO
SANGAMO THERAPEUTICS, INC
Feb 25, 2025
Award(A)
Direct
120K shares-
SGMO
SANGAMO THERAPEUTICS, INC
Feb 25, 2025
Tax Payment(F)
Direct
1.4K shares at avg. $0.96$1K
SGMO
SANGAMO THERAPEUTICS, INC
Feb 24, 2025
Tax Payment(F)
Direct
1.8K shares at avg. $1.00$2K
ORGO
Organogenesis Holdings Inc.
Feb 19, 2025
Award(A)
Direct
49.6K shares-
SGMO
SANGAMO THERAPEUTICS, INC
Jan 22, 2025
Tax Payment(F)
Direct
129.2K shares at avg. $1.15$149K
SGMO
SANGAMO THERAPEUTICS, INC
Nov 25, 2024
Tax Payment(F)
Direct
1.4K shares at avg. $1.94$3K
SGMO
SANGAMO THERAPEUTICS, INC
Nov 24, 2024
Tax Payment(F)
Direct
1.8K shares at avg. $1.88$3K

		Type	Shares	Price		Ownership
Feb 18, 2026	ORGO Organogenesis Holdings Inc.	Award(A)	48,828	-	$0	Direct
Jan 22, 2026	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	36,676	$0.40	$14,615	Direct
Nov 24, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	2,544	$0.42	$1,060	Direct
Oct 22, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	45,225	$0.66	$29,849	Direct
Aug 24, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	1,792	$0.59	$1,051	Direct
Jul 22, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	31,866	$0.48	$15,289	Direct
May 24, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	1,792	$0.47	$848	Direct
Apr 22, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	31,866	$0.78	$24,738	Direct
Feb 25, 2025	SGMO SANGAMO THERAPEUTICS, INC	Award(A)	120,000	-	-	Direct
Feb 25, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	1,375	$0.96	$1,315	Direct
Feb 24, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	1,792	$1.00	$1,792	Direct
Feb 19, 2025	ORGO Organogenesis Holdings Inc.	Award(A)	49,575	-	-	Direct
Jan 22, 2025	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	129,242	$1.15	$148,628	Direct
Nov 25, 2024	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	1,371	$1.94	$2,660	Direct
Nov 24, 2024	SGMO SANGAMO THERAPEUTICS, INC	Tax Payment(F)	1,787	$1.88	$3,360	Direct

1-15 of 15 transactions

About Duraibabu Prathyusha

Duraibabu Prathyusha (SEC CIK 0001779092) files insider reports with the SEC as Director of Organogenesis Holdings Inc. (ORGO) and PRINCIPAL FINANCIAL OFFICER of SANGAMO THERAPEUTICS, INC (SGMO).

Signal8 holds 12 ownership filings by Duraibabu Prathyusha, all Form 4s, filed between Nov 26, 2024 and Feb 20, 2026. Those filings report 15 transactions, from Nov 24, 2024 to Feb 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Duraibabu Prathyusha's filings is in CANTON, MA.

Recent filings by Duraibabu Prathyusha

Feb 18, 2026: Grant or award of ORGO shares (Form 4, code A).
Jan 22, 2026: Tax withholding of SGMO shares (Form 4, code F).
Nov 24, 2025: Tax withholding of SGMO shares (Form 4, code F).
Oct 22, 2025: Tax withholding of SGMO shares (Form 4, code F).
Aug 24, 2025: Tax withholding of SGMO shares (Form 4, code F).

Other insiders filing for Organogenesis Holdings Inc. (ORGO)

Grow Brian, Chief Commercial Officer
Leibowitz Arthur S, Director
Driscoll Michael Joseph, Director
Cavorsi Robert, Vice President, Strategy
Montecalvo Antonio S., Vice President, Health Policy
Gillheeney Gary S., President and CEO

How to read Form 4 transaction codes